TRPM3 channel stimulated by pregnenolone sulphate in synovial fibroblasts and negatively coupled to hyaluronan

BMC Musculoskeletal Disorders

Volumn 11, Issue , 2010, Pages

  Ciurtin, Coziana ^a,b   Majeed, Yasser ^a   Naylor, Jacqueline ^a   Sukumar, Piruthivi ^a   English, Anne A ^a   Emery, Paul ^a   Beech, David J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING ANTIBODY; HYALURONIC ACID; MESSENGER RNA; PREGNENOLONE SULFATE; SPHINGOSINE; TRANSIENT RECEPTOR POTENTIAL CHANNEL M3; VANILLOID RECEPTOR 4; PREGNENOLONE; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRPM3 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL CULTURE; FIBROBLAST; HUMAN; HUMAN TISSUE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; ANIMAL; CALCIUM SIGNALING; CELL LINE; CHEMISTRY; CHO CELL; CRICETULUS; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; GENETICS; HAMSTER; METABOLISM; PATHOLOGY; PHYSIOLOGY; RABBIT; SYNOVIUM;

ANIMALS; ANTIBODIES, BLOCKING; ARTHRITIS, RHEUMATOID; CALCIUM SIGNALING; CELL LINE; CHO CELLS; CRICETINAE; CRICETULUS; DRUG SYNERGISM; FIBROBLASTS; HUMANS; HYALURONIC ACID; PREGNENOLONE; RABBITS; SPHINGOSINE; SYNOVIAL MEMBRANE; TRPM CATION CHANNELS;

EID: 77953006068     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-11-111     Document Type: Article

References (25)

1. Transient receptor potential cation channels in disease. B Nilius G Owsianik T Voets JA Peters, Physiol Rev 2007 87 1 165 217 10.1152/physrev.00021. 2006 17237345
2. TRP channels. K Venkatachalam C Montell, Annu Rev Biochem 2007 76 387 417 10.1146/annurev.biochem.75.103004.142819 17579562
3. TRPC channel activation by extracellular thioredoxin. SZ Xu P Sukumar F Zeng J Li A Jairaman A English, et al. Nature 2008 451 7174 69 72 10.1038/nature06414 18172497
4. Thermosensitive TRP ion channels mediate cytosolic calcium response in human synoviocytes. MY Kochukov TA McNearney Y Fu KN Westlund, Am J Physiol Cell Physiol 2006 291 3 424 32 10.1152/ajpcell.00553.2005 16597917
5. 2+ in human synoviocytes. Y Itoh N Hatano H Hayashi K Onozaki K Miyazawa K Muraki, Am J Physiol Cell Physiol 2009 297 5 1082 90 10.1152/ajpcell.00204.2009 19759329
6. Expression and characterization of human transient receptor potential melastatin 3 (hTRPM3). N Lee J Chen L Sun S Wu KR Gray A Rich M Huang JH Lin JN Feder EB Janovitz PC Levesque MA Blanar, J Biol Chem 2003 278 23 20890 7 10.1074/jbc.M211232200 12672827
7. Molecular and functional characterization of the melastatin-related cation channel TRPM3. C Grimm R Kraft S Sauerbruch G Schultz C Harteneck, J Biol Chem 2003 278 24 21493 501 10.1074/jbc.M300945200 12672799
8. Activation of the melastatin-related cation channel TRPM3 by D-erythro-sphingosine. C Grimm R Kraft G Schultz C Harteneck, Mol Pharmacol 2005 67 3 798 805 10.1124/mol.104.006734 15550678
9. Trpm3. J Oberwinkler SE Phillipp, Handb Exp Pharmacol 2007 179 253 67 full-text 17217062
10. Transient receptor potential M3 channels are ionotropic steroid receptors in pancreatic beta cells. TF Wagner S Loch S Lambert I Straub S Mannebach I Mathar M Düfer A Lis V Flockerzi SE Philipp J Oberwinkler, Nat Cell Biol 2008 10 12 1421 30 10.1038/ncb1801 18978782
11. Production of a specific extracellular inhibitor of TRPM3 channels. J Naylor CJ Milligan F Zeng C Jones DJ Beech, Br J Pharmacol 2008 155 4 567 73 10.1038/bjp.2008.283 18604232
12. Neurosteroid modulation of ionotropic glutamate receptors and excitatory synaptic transmission. M Sedlcek M Korínek M Petrovic O Cais E Adamusov H Chodounsk L Vyklick Physiol Res 2008 57 Suppl 3 49 57 18481915
13. Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance. P Zheng, Prog Neurobiol 2009 89 2 134 52 10.1016/j.pneurobio.2009.07.001 19595736
14. Monoclonal expansion of synoviocytes in rheumatoid arthritis. F Imamura H Aono T Hasunuma T Sumida H Tateishi S Maruo K Nishioka, Arthritis Rheum 1998 41 11 1979 86 10.1002/1529-0131(199811)41:11<1979:AID-ART13>3.0.CO;2-C 9811053
15. Tumour necrosis factor alpha (TNF-alpha) interferes with Fas-mediated apoptotic cell death on rheumatoid arthritis (RA) synovial cells: a possible mechanism of rheumatoid synovial hyperplasia and a clinical benefit of anti-TNF-alpha therapy for RA. S Ohshima T Mima M Sasai K Nishioka M Shimizu N Murata H Yoshikawa K Nakanishi M Suemura RV McCloskey T Kishimoto Y Saeki, Cytokine 2000 12 3 281 8 10.1006/cyto.1999.0552 10704256
16. Synovial cell activation. J Stanczyk C Ospelt RE Gay S Gay, Curr Opin Rheumatol 2006 18 3 262 7 10.1097/01.bor.0000218947.42730.dd 16582690
17. Aspects of the biology of hyaluronan, a largely neglected but extremely versatile molecule. KM Stuhlmeier, Wien Med Wochenschr 2006 156 21-22 563 8 10.1007/s10354-006-0351-0 17160372
18. Hyaluronic acid: targeting immune modulatory components of the extracellular matrix in atherosclerosis. PT Bot IE Hoefer JJ Piek G Pasterkamp, Curr Med Chem 2008 15 8 786 91 10.2174/092986708783955554 18393848
19. Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4. V Voelcker C Gebhardt M Averbeck A Saalbach V Wolf F Weih J Sleeman U Anderegg J Simon, Exp Dermatol 2008 17 2 100 7 10.1111/j.1600-0625.2007.00638.x 18031543
20. HIG-82: an established cell line from rabbit periarticular soft tissue, which retains the "activatable" phenotype. HI Georgescu D Mendelow CH Evans, In Vitro Cell Dev Biol 1988 24 10 1015 22 10.1007/BF02620875 2846503
21. Activation of TRPV4 channels (hVRL-2/mTRP12) by phorbol derivatives. H Watanabe JB Davis D Smart JC Jerman GD Smith P Hayes J Vriens W Cairns U Wissenbach J Prenen V Flockerzi G Droogmans CD Benham B Nilius, J Biol Chem 2002 277 16 13569 77 10.1074/jbc.M200062200 11827975
22. Serum levels of pregnenolone and 17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: relation to other adrenal hormones. D Vogl W Falk M Dorner J Scholmerich RH Straub, J Rheumatol 2003 30 2 269 75 12563679
23. Serum dehydroepiandrosterone, dehydroepiandrosterone sulfate, and pregnenolone sulfate concentrations in patients with hyperthyroidism and hypothyroidism. N Tagawa J Tamanaka A Fujinami Y Kobayashi T Takano S Fukata K Kuma H Tada N Amino, Clin Chem 2000 46 4 523 8 10759476
24. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis. RH Straub L Paimela R Peltomaa J Scholmerich M Leirisalo-Repo, Arthritis Rheum 2002 46 3 654 62 10.1002/art.10177 11920401
25. Pregnenolone sulphate-and cholesterol-regulated TRPM3 channels coupled to vascular smooth muscle secretion and contraction. J Naylor J Li CJ Milligan F Zeng P Sukumar B Hou A Sedo N Yuldasheva Y Majeed D Beri S Jiang VA Seymour L McKeown B Kumar C Harteneck D O'Regan SB Wheatcroft MT Kearney C Jones KE Porter DJ Beech, Circ Res 2010 106 9 1507 15 10.1161/CIRCRESAHA.110.219329 20360246